Cory Booker is the only Democrat with a data-driven electability argument

It's not a strong case, but that's the point

Cory Booker.
(Image credit: Illustrated | Alberto E. Rodriguez/Getty Images, Aerial3/iStock)

The Democratic base is supposedly obsessed with electability in the presidential primary. A recent poll showed 60 percent of primary voters think it is more important to nominate a candidate who can beat Trump than one which they agree with on the issues. Which is why it is surprising that New Jersey Sen. Cory Booker's campaign hasn't gotten more traction, since he is the only one with a real data-driven electability argument.

Similarly surprising is that a major thrust of Joe Biden's current campaign is that there is something unique about him, a white male moderate with decades in politics, that makes him uniquely electable. Yet beside the fact that significantly more voters know who he is compared to the other candidates, a deficit that would be quickly rectified in a general election campaign, the past doesn't indicate anything about him in particular that is especially "electable."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Jon Walker

Jon Walker is the author of After Legalization: Understanding the Future of Marijuana Policy. He is a freelance reporter and policy analyst that focuses on health care, drug policy, and politics.